Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,556
Closed -$271K 404
2021
Q4
$271K Buy
1,556
+122
+9% +$20.3K 0.03% 365
2021
Q3
$237K Buy
1,434
+117
+9% +$20.1K 0.03% 393
2021
Q2
$237K Buy
+1,317
New +$240K 0.03% 380
2019
Q3
Sell
-24
Closed -$3K 300
2019
Q2
$3K Hold
24
﹤0.01% 628
2019
Q1
$3K Hold
24
﹤0.01% 609
2018
Q4
$3K Hold
24
﹤0.01% 583
2018
Q3
$3K Buy
24
+4
+20% +$568 ﹤0.01% 591
2018
Q2
$1K Buy
20
+11
+122% +$1.36K ﹤0.01% 743
2018
Q1
$1K Hold
9
﹤0.01% 697
2017
Q4
$1K Buy
+9
New +$1.23K ﹤0.01% 677

Other funds holding CLX

Avestar Capital's CLX Position: Q1 2022 in Review

Avestar Capital sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,556 shares — an estimated $271K sold.

Avestar Capital first reported a position in CLX in Q4 2017 and held it in 10 quarters. The position peaked at $271K in Q4 2021. 1,093 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Avestar Capital reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Avestar Capital sold 1,556 Clorox shares in Q1 2022, an estimated $271K.
  • Avestar Capital first reported a position in Clorox in Q4 2017 and held it in 10 quarters.
  • Avestar Capital's Clorox position peaked at $271K in Q4 2021.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Avestar Capital's 13F filing for Q1 2022, filed 26 Apr 2022.